Related Articles
Sorafenib inhibits cancer side population cells by targeting c‑Jun N‑terminal kinase signaling
Ursodeoxycholic acid suppresses epithelial-mesenchymal transition and cancer stem cell formation by reducing the levels of peroxiredoxin II and reactive oxygen species in pancreatic cancer cells
Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line
Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway
Tumor‑treating fields in combination with sorafenib restrain the proliferation of liver cancer <em>in vitro</em>